OMG! Tuesday 30th March: Summary of last week’s newsletter

Share On Facebook
share on Linkedin

The OMG newsletter recommends at least 15 companies each month, using the writers’ experience of small caps to give you a winning edge. Last week they wrote about Kromek, Proteome and Itaconix. Read about these Opportunities 4 Material Gains!


Wednesday Tip

Our Wednesday Tip on the 24th March was a Kromek (LSE: KMK) at 15.75p. Amongst other things it has a  bio-security automatic system  which  is (re) designed to detect Covid in the atmosphere in areas of high footfall such as hospitals, retail outlets and airports. The part patented system is on trials and can detect the Covid virus in the air in real time at max rate of 3x per hour. If the Covid in the  air is above the ‘safe rate’ action can be taken to reduce the potential threat of spreading.  If this prevents further lockdowns, then it would be hard to dispute its value. Recently £13m was raised at 15p and the shares are well funded to achieve success. Buy


Results Previews

Proteome (Aim: Prm) Friday’s second Trading up-date for the year-end to December 2020, stated that profits to be reported are to be materially higher when Finals are reported on Thursday. This is primarily due to higher-than-expected royalty receipts from Thermo Scientific for the last quarter of 2020. The is a substantial order book  as delayed business is carried forward and traction from its key partnerships is building. Now its profitable further funding would only be needed for scaling production to meet orders. Buy

Itaconix (LSE: ITX) 6.15p reports finals on Tuesday losses are decreasing as it commercializes its sustainable plant-based polymers which are essential ingredients to help differentiate everyday consumer products. The marketing and sales teams have been expanded along and a new vice president of operations appointed. ITX report increasing enquiries about its polymers from major Brands seeking to improve product performance and bolster the sustainability credentials. ITX polymers have been used in a few major new brand launches and reformulations of existing brands in dishwashing detergents, hair styling products, and deodorizing cleaners. In July 2020£1.8m was raised at 1.1p and there is likely to be a further fund raise to achieve profitability. Watching brief


Reviews Section  21st March

EMR – 49.5p – Recovering gently

DEST – 154.5p – Study results by end of March

BOKU – 174p – Identity improving

EYE – 467p – Generating cash

OPTI – 53p – Expanding product range

SBTX – 52p – Share price rises despite Optibiotix sale

KWS – 2374p – Australian purchase

JSG – 153.2p – Ready for recovery

TSG – 118p – Cash bid

SUR – 68.5p – Chairman steps down

HDD – 26p – Recovery in demand later this year

GHS – 1400p – Increased Universe stake

LSAI – 0.43p – Strategic review continues


Finally ……….. markets are paused  as while key economic figures are improving its from a low base and it seems  too early to get too excited about recovery.


OMG! , Opportunity for Massive Gains is a Premium Newsletter on ADVFN. To get trips like this every week, sign up here.


CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Plc. ADVFN Plc does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.

Leave A Reply

Do you want to write for our Newspaper? Get in touch:

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221006 21:33:53